FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileFisher & Paykel Healthcare Corporation Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
FPH.AX
Fisher & Paykel Healthcare Corporation Limited Stock AnalysisComprehensive stock analysis for Fisher & Paykel Healthcare Corporation Limited (FPH.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisFPH.AX
FPH.AX
Fisher & Paykel Healthcare Corporation Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
FPH.AX
  1. Home
  2. Stocks
  3. Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited

🇦🇺FPH.AX•ASX

Fisher & Paykel Healthcare Corporation Limited

🇦🇺FPH.AX•ASX
P/E ratio
60.77

Your view on FPH.AX

P/E
60.77
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Fisher & Paykel Healthcare Corporation Limited

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Lewis G. Gradon
Headquarters
15 Maurice Paykel Place, Auckland, AUK, NZ
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Lewis G. Gradon
Headquarters
15 Maurice Paykel Place, Auckland, AUK, NZ
Description

Fisher & Paykel Healthcare Corporation Limited, operating with its various subsidiaries, is a global innovator in medical device technology. The company specializes in the design, production, and worldwide distribution of sophisticated products and systems.

These solutions primarily cater to acute and chronic respiratory care, support during surgical procedures, and the treatment of obstructive sleep apnea (OSA) in both clinical settings and home environments.

Their product lineup includes notable items such as the Airvo 2, a humidified nasal high flow system; Optiflow, designed for nasal high flow therapy; and the F&P 850 System, which offers both non-invasive and invasive ventilation capabilities.

For infant care, the company supplies respiratory products used in resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Hospital-grade offerings comprise humidification devices, breathing circuits, chambers, diverse masks, nasal cannulas, surgical accessories, and various interfaces.

For homecare users, Fisher & Paykel provides masks, CPAP devices, data management software, humidifiers, and complementary accessories. Established in 1934, the company maintains its headquarters in Auckland, New Zealand.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Fisher & Paykel Healthcare Corporation Limited from FRC's valuation model, read against the market price. FPH.AX last traded at AUD 34.94, 60.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Fisher & Paykel Healthcare Corporation Limited. Starting points for Fisher & Paykel Healthcare Corporation Limited: P/E 60.8, EPS AUD 0.80, beta 0.89 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Fisher & Paykel Healthcare Corporation Limited. Fisher & Paykel Healthcare Corporation Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Fisher & Paykel Healthcare Corporation Limited. Trailing twelve-month EPS for Fisher & Paykel Healthcare Corporation Limited stands at AUD 0.80. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterJun 2025Next quarterSep 2025This yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateNZD 0.00NZD 0.34NZD 0.96NZD 1.11
Lowest estimateNZD 0.00NZD 0.34NZD 0.92NZD 1.02
Highest estimateNZD 0.00NZD 0.34NZD 0.99NZD 1.15
Number of analysts0188
A year agoNZD 0.20NZD 0.28NZD 0.80—
Growth vs a year ago−100.0%+21.3%+20.1%—

Revenue estimates

TotalThis quarterJun 2025Next quarterSep 2025This yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateNZD 1.25BNZD 1.07BNZD 2.60BNZD 2.90B
Lowest estimateNZD 1.25BNZD 1.07BNZD 2.56BNZD 2.81B
Highest estimateNZD 1.25BNZD 1.07BNZD 2.65BNZD 2.96B
Number of analysts411616
A year agoNZD 570.90MNZD 692.80MNZD 2.36B—
Growth vs a year ago+118.9%+53.9%+10.3%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Fisher & Paykel Healthcare Corporation Limited. Fisher & Paykel Healthcare Corporation Limited has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold FPH.AX17 companies · 7 funds
Compare FPH.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
BAXBaxter International Inc.HealthcareMedical - Instruments & Supplies$13.5B
BDXBecton, Dickinson and CompanyHealthcareMedical - Instruments & Supplies$58.9B
COOThe Cooper Companies, Inc.HealthcareMedical - Instruments & Supplies$11.6B
MMSIMerit Medical Systems, Inc.HealthcareMedical - Instruments & Supplies$5.1B
RMDResMed Inc.HealthcareMedical - Instruments & Supplies$34.1B
More Medical - Instruments & Supplies companies
TickerTypeCompanySectorExchangeMkt cap
HOCPFHOYA CorporationHealthcareOTC$64.6B
HOCPYHOYA CorporationHealthcareOTC$63.6B
HRALHear AtLast Holdings, Inc.HealthcareOTC$396
ICUIICU Medical, Inc.HealthcareNASDAQ$4.5B
IMTHInnovative MedTech Inc.HealthcareOTC$89,758
INNDInnerScope Hearing Technologies, Inc.HealthcareOTC$2,756
ISRGIntuitive Surgical, Inc.HealthcareNASDAQ$145.9B
JNDOFJINS HOLDINGS Inc.HealthcareOTC$531.0M
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.HealthcareNASDAQ$1.7B
KRMDKORU Medical Systems, Inc.HealthcareNASDAQ$149.6M
KSRBFKossan Rubber Industries BhdHealthcareOTC$841.7M
LFPILifePoint, Inc.HealthcareOTC$2,086
ETFs holding Fisher & Paykel Healthcare Corporation Limited
TickerFundFund assets% of the fund
VAS.AXVanguard Australian Shares Index ETF$27.0B in assets0.25%
A200.AXBetaShares - Australia 200 ETF$11.4B in assets0.27%
IOZ.AXiShares Core S&P/ASX 200 ETF$9.8B in assets0.27%
STW.AXState Street SPDR S&P/ASX 200 ETF$6.6B in assets0.27%
FAIR.AXBetaShares - Australian Sustainability Leaders ETF$1.1B in assets1.42%
EX20.AXBetaShares - Australian Ex-20 Portfolio Diversifier ETF$687M in assets0.75%
GEAR.AXBetaShares - Geared Australian Equities Complex ETF$554M in assets0.57%

Largest holders first, then the funds most concentrated in FPH.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Fisher & Paykel Healthcare Corporation Limited. Coverage tracks Fisher & Paykel Healthcare Corporation Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Fisher & Paykel Healthcare Corporation Limited.

FPH.AX AnalysisGood
Past
4
Growth
5
Health
5
Profit
4
Value
1